Dermatologic Consequences of Substandard, Spurious, Falsely Labeled, Falsified, and Counterfeit Medications
Document Type
Journal Article
Publication Date
4-1-2022
Journal
Dermatologic clinics
Volume
40
Issue
2
DOI
10.1016/j.det.2021.12.008
Keywords
Counterfeit drugs; Crime; Drug eruptions; Fraud; Pharmaceutical preparations; Substandard drugs
Abstract
This article explores dermatologic consequences of substandard, spurious, falsely labeled, falsified, and counterfeit (SSFFC) pharmaceutical products. Many of these SSFFC products are neither safe nor effective, and are more likely to cause adverse events than the proper preparations. These products also affect the health of populations by generating drug-resistant pathogens and failing to control the spread of disease. This article reviews classification systems for fraudulent medications, provides a general overview of medical and public health problems associated with substandard medications, provides examples of dermatologic consequences of each category, and presents recommended steps to take when clinicians encounter suspected SSFFC products.
APA Citation
Schwartzman, Gabrielle H.; Dekker, Paige K.; Silverstein, Anna S.; Fontecilla, Natalia M.; and Norton, Scott A., "Dermatologic Consequences of Substandard, Spurious, Falsely Labeled, Falsified, and Counterfeit Medications" (2022). GW Authored Works. Paper 510.
https://hsrc.himmelfarb.gwu.edu/gwhpubs/510
Department
Dermatology